John Lisotto v. New Prime, Inc.

647 F. App'x 259
CourtCourt of Appeals for the Fourth Circuit
DecidedMay 3, 2016
Docket15-1273
StatusUnpublished

This text of 647 F. App'x 259 (John Lisotto v. New Prime, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
John Lisotto v. New Prime, Inc., 647 F. App'x 259 (4th Cir. 2016).

Opinion

Vacated and remanded by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

John D. Lisotto (“Appellant”) filed an Americans with Disabilities Act (“ADA”) claim against Appellee New Prime, Inc. (“Prime”) after Prime failed to hire him as a truck driver. Prime, contending that Appellant should have exhausted his administrative remedies with the Federal Motor Carrier Safety Administration (“FMCSA”), moved to dismiss the complaint. The district court agreed and dismissed the complaint without prejudice.

The FMCSA regulation upon which the district court relied contemplates “a disagreement between the physician for the driver and the physician for the motor carrier concerning the driver’s qualifications.” 49 C.F.R. § 391.47(b)(2). However, because the parties did not “disagree[ ]” about Appellant’s qualifications at the time Prime denied employment to Appellant, 49 C.F.R, § 391.47(b)(2) is inapplicable. Therefore, we vacate the district court’s judgment and remand.

I.

Appellant’s complaint sets forth the following allegations, which we accept as true. See Johnson v. Am. Towers, LLC, 781 F.3d 693, 709 (4th Cir.2015).

On August 19, 2010, Appellant, an experienced commercial truck driver, applied for a driver position with Prime. Appellant began “trucking” in 1971 and had •around seven years’ experience as a long-distance truck driver hauling gasoline, diesel fuel, and ethanol throughout the United States. J.A. 6. 1 At the time of his application to Prime, Appellant was employed as a correctional officer for the South Carolina Department of Corrections, earning around $30,000 a year.

On August 27, 2010, a recruiter from Prime, Sheryl Lindsay, sent Appellant an email stating he was approved to attend Prime’s orientation program in Springfield, Missouri. Lindsay also explained that as part of the hiring process, Appel *261 lant would be required to pass a physical examination and drug screen in accordance with FMCSA standards. Lindsay bought Appellant a one-way bus ticket to Springfield and explained that after a successful orientation, he would receive his assigned truck and drive back to South Carolina to work out of Columbia.

Appellant had a sleep disorder “believed to be or diagnosed as narcolepsy.” J.A. 7. In anticipation of his physical and drug screen, he obtained a letter from his physician, Dr. Crook. The letter explained that Appellant took Dexedrine, a type of amphetamine, to manage the sleep disorder. Dr. Crook opined “that the prescribed medication would not adversely affect [Appellant’s] ability to safely operate a commercial motor vehicle, as [Appellant] had for many years been driving commercial trucks safely ... while taking [Dexedrine] and had experienced no problems with narcolepsy.” Id. at 10-11.

On September 22, 2010, Appellant, having quit his job with the Department of Corrections, travelled to Springfield for orientation. He reported for his physical examination and drug test and explained to Prime’s medical examiner, Dr. Abraham, that' he was taking Dexedrine “to address a condition believed to be or diagnosed as narcolepsy.” J.A. 10. He gave Dr. Abraham the letter from Dr. Crook and showed him his prescription for Dexedrine. Dr. Abraham did not determine that Appellant was unqualified for the position because he had narcolepsy; rather, he noted that Appellant “needs to be off Dexedrine at least 1 month.” Id. at 11 (alteration omitted). Dr. Abraham further noted that Provigil is the “[o]nly medication] ... taken for narcolepsy” that Prime would accept, and Appellant “need[ed] to be on it for at least 6 weeks [and] document[] [his] stability” before beginning employment with Prime. Id.

Appellant returned to orientation, and about an hour later, one of Prime’s nurses called Appellant out of his session and told him “he could not work for Prime because he had tested positive for amphetamines.” J.A. 11. Echoing Dr. Abraham, the nurse said Prime would accept truckers taking Provigil, but not Dexedrine, and instructed him to return home and take Provigil for six weeks to see how it would affect him. Appellant left Springfield and went back to South Carolina to comply with Prime’s directives.

Two days later, on September 24, 2010, Prime’s Medical Review Officer (“MRO”), Dr. Mauldin, phoned Appellant and stated “he needed to hear from [Appellant’s] doctor about his medical condition and prescribed medication.” J.A. 11; see also 49 C.F.R. § 40.129(a)(4) (when a drug test result is positive, before “verifying]” the test, an MRO must “conduct a verification 1 interview [which] must include direct contact in person or by telephone between [the MRO] and the employee”); 2 id. § 40.131(a) (“When ... the MRO ... receive[s] a confirmed positive ... test result from the laboratory, [he or she] must contact the employee directly ... on a confidential basis, to determine whether the employee wants to discuss the test result.”). Dr. Mauldin claimed that if he did not hear from Appellant’s doctor within five days, he would report “a positive drug test for amphetamines” to the Department of Transportation (“DOT”). J.A. 11. Appellant called his physician, Dr. Crook, “right away,” and explained Dr. Mauldin’s request. Id. Dr. Crook phoned Dr. Maul- *262 din on September 27, but no one answered the call. He “persisted in trying to reach Dr. Mauldin but was never able to reach him or anyone else in his office.” Id. at 20.

On September 27, 2010, Dr. Crook changed Appellant’s medication to Provigil, and he experienced no detrimental side effects. On November 1, Appellant called Lindsay and told her he had complied with Dr. Abraham’s and the nurse’s directives. Lindsay forwarded the call to Prime’s personnel office, and an employee in that office told him, “You cannot work for Prime because you tested positive for amphetamines” and hung up. J.A. 12.

On November 19, 2010, Appellant wrote to Dr. Mauldin, asking that he “reevaluate the circumstances of the drug test he had taken during his physical on September 22, 2010.” J.A. 12, 30. Appellant explained,

I am not saying the test was incorrect, it was correct. However I was under [Dr. Crook’s] care and he tried to contact your office numerous times and could not reach anyone and get an answer.... [Dr. Crook] changed my medication to one acceptable to your office and the [DOT]
Thank you for your consideration. This is effecting [sic] my career and my livelihood through no fault of my own.

Id. at 30. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Campbell v. Federal Express Corp.
918 F. Supp. 912 (D. Maryland, 1996)
Stevens v. Coach U.S.A.
386 F. Supp. 2d 55 (D. Connecticut, 2005)
Robert Johnson v. American Towers, LLC
781 F.3d 693 (Fourth Circuit, 2015)
J. DeMasters v. Carilion Clinic
796 F.3d 409 (Fourth Circuit, 2015)
SD3, LLC v. Black & Decker (U.S.) Inc.
801 F.3d 412 (Fourth Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
647 F. App'x 259, Counsel Stack Legal Research, https://law.counselstack.com/opinion/john-lisotto-v-new-prime-inc-ca4-2016.